Form 8-K - Current report:
SEC Accession No. 0001104659-24-124097
Filing Date
2024-11-29
Accepted
2024-11-29 16:21:18
Documents
19
Period of Report
2024-11-26
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2429720d2_8k.htm   iXBRL 8-K 33360
2 EXHIBIT 3.1 tm2429720d2_ex3-1.htm EX-3.1 9156
3 EXHIBIT 99.1 tm2429720d2_ex99-1.htm EX-99.1 9754
4 EXHIBIT 99.2 tm2429720d2_ex99-2.htm EX-99.2 9376
8 GRAPHIC tm2429720d2_ex99-1img01.jpg GRAPHIC 4791
9 GRAPHIC tm2429720d2_ex99-1img02.jpg GRAPHIC 1783
10 GRAPHIC tm2429720d2_ex99-2img01.jpg GRAPHIC 4791
  Complete submission text file 0001104659-24-124097.txt   268276

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA rnaz-20241126.xsd EX-101.SCH 3054
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE rnaz-20241126_lab.xml EX-101.LAB 34240
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rnaz-20241126_pre.xml EX-101.PRE 22385
21 EXTRACTED XBRL INSTANCE DOCUMENT tm2429720d2_8k_htm.xml XML 3912
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Filer) CIK: 0001829635 (see all company filings)

EIN.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40363 | Film No.: 241516576
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)